Escudero-Ortiz, V.; DomÃnguez-Leñero, V.; Catalán-Latorre, A.; Rebollo-Liceaga, J.; Sureda, M.
Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics 2022, 14, 1216.
https://doi.org/10.3390/pharmaceutics14061216
AMA Style
Escudero-Ortiz V, DomÃnguez-Leñero V, Catalán-Latorre A, Rebollo-Liceaga J, Sureda M.
Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics. 2022; 14(6):1216.
https://doi.org/10.3390/pharmaceutics14061216
Chicago/Turabian Style
Escudero-Ortiz, Vanesa, Vanessa DomÃnguez-Leñero, Ana Catalán-Latorre, Joseba Rebollo-Liceaga, and Manuel Sureda.
2022. "Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study" Pharmaceutics 14, no. 6: 1216.
https://doi.org/10.3390/pharmaceutics14061216
APA Style
Escudero-Ortiz, V., DomÃnguez-Leñero, V., Catalán-Latorre, A., Rebollo-Liceaga, J., & Sureda, M.
(2022). Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics, 14(6), 1216.
https://doi.org/10.3390/pharmaceutics14061216